ARTICLE | Company News
Visible Genetics reaches milestone
February 18, 2000 8:00 AM UTC
As part of a service contract with Glaxo Wellcome (LSE:GLXO), VGIN said it determined the sequence of the HIV-1 protease gene and parts of the HIV-1 reverse transcriptase gene involved in drug resista...